What is Nobel's earnings per share (EPS)?

Nobel (NBLWF) reported diluted earnings per share of $1.35 for fiscal year 2025. This represents a -54.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nobel Financials

NBLWF

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Nobel (NBLWF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NBLWF FY2025 2026-04-22

A working-capital release and higher financing costs now shape results more than modest revenue growth.

FY2025’s cash-flow surge did not reflect stronger earnings: operating cash flow reached $951.7M while net income fell to $216.7M, which fits the sharp reduction in receivables rather than a healthier margin structure. The cleaner reading is that liquidity improved through working-capital release even as operating margin compressed to 12.7% from 19.8%.

The company still has an equity-heavy balance sheet, because equity remains larger than total liabilities and current assets still cover current obligations, but its earnings now carry a much heavier financing burden. Interest expense rose to $162.4M from $59.1M in FY2023, so more operating profit is diverted before it reaches net income.

FY2025 dividends paid of $320.4M exceeded net income of $216.7M, which matters because payout capacity cannot be judged from earnings alone here. The distribution was supported by strong operating cash generation that year, although part of that support came from cash being freed up from receivables rather than from better margins.

Financial Health Signals

Financial health score pending refresh

We are recalculating Nobel's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

5/8

Nobel passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

4.39x

For every $1 of reported earnings, Nobel generates $4.39 in operating cash flow ($951.7M OCF vs $216.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.6x

Nobel earns $2.6 in operating income for every $1 of interest expense ($415.6M vs $162.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.3B

YoY+7.4%

5Y CAGR+27.8%

Nobel generated $3.3B in revenue in fiscal year 2025. This represents an increase of 7.4% from the prior year.

EBITDA

N/A

Net Income

$216.7M

YoY-51.7%

Nobel reported $216.7M in net income in fiscal year 2025. This represents a decrease of 51.7% from the prior year.

EPS (Diluted)

$1.35

YoY-54.4%

Nobel earned $1.35 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 54.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$471.4M

YoY+90.6%

5Y CAGR+33.3%

Nobel held $471.4M in cash against $2.0B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.00

YoY+11.1%

Nobel paid $2.00 per share in dividends in fiscal year 2025. This represents an increase of 11.1% from the prior year.

Shares Outstanding

159M

YoY+0.0%

Nobel had 159M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

12.7%

YoY-7.1pp

5Y CAGR+435.4pp

Nobel's operating margin was 12.7% in fiscal year 2025, reflecting core business profitability. This is down 7.1 percentage points from the prior year.

Net Margin

6.6%

YoY-8.1pp

5Y CAGR+419.2pp

Nobel's net profit margin was 6.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8.1 percentage points from the prior year.

Return on Equity

4.8%

YoY-4.9pp

Nobel's ROE was 4.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$20.0M

YoY-93.3%

Nobel spent $20.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 93.3% from the prior year.

Capital Expenditures

N/A

NBLWF Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.3B+7.4%	$3.1B+18.1%	$2.6B+83.1%	$1.4B+83.5%	$770.3M-20.1%	$964.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$133.1M-5.2%	$140.5M+9.4%	$128.4M+56.3%	$82.2M+31.5%	$62.5M-48.5%	$121.2M
Operating Income	$415.6M-31.2%	$604.0M+5.1%	$574.7M+151.2%	$228.8M+276.1%	$60.8M+101.5%	-$4.1B
Interest Expense	$162.4M+72.4%	$94.2M+59.3%	$59.1M+38.4%	$42.7M+34.6%	$31.7M-80.7%	$164.7M
Income Tax	$56.4M+28.2%	$44.0M+45.0%	$30.3M+34.5%	$22.6M+6078.9%	$365K+100.1%	-$260.4M
Net Income	$216.7M-51.7%	$448.4M-7.0%	$481.9M+185.2%	$168.9M+65.7%	$102.0M+102.6%	-$4.0B
EPS (Diluted)	$1.35-54.4%	$2.96-10.8%	$3.32+91.9%	$1.73+14.6%	$1.51+109.5%	$-15.86

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$785.7M+2.8%	$764.4M-4.2%	$798.0M-6.0%	$848.7M-3.0%	$874.5M-5.7%	$927.3M+15.8%	$800.5M+15.5%	$692.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$30.0M+1.3%	$29.7M-10.9%	$33.3M-4.8%	$35.0M-0.7%	$35.2M+12.6%	$31.3M-28.3%	$43.6M+9.9%	$39.7M
Operating Income	$225.3M+429.4%	$42.6M-15.6%	$50.4M-62.7%	$135.3M-27.8%	$187.3M+9.6%	$171.0M+48.1%	$115.5M-45.0%	$210.0M
Interest Expense	$40.6M-2.1%	$41.4M+2.4%	$40.5M+1.2%	$40.0M-1.2%	$40.5M+1.9%	$39.7M+59.2%	$25.0M+108.0%	$12.0M
Income Tax	$72.9M+200.1%	-$72.8M-329.6%	$31.7M-44.4%	$57.1M+41.3%	$40.4M+45.3%	$27.8M-12.0%	$31.6M+704.6%	-$5.2M
Net Income	$120.7M+39.3%	$86.6M+510.7%	-$21.1M-149.2%	$42.9M-60.4%	$108.3M+12.1%	$96.6M+57.9%	$61.2M-68.6%	$195.0M
EPS (Diluted)	$0.75	N/A	$-0.13-148.1%	$0.27-59.7%	$0.67	N/A	$0.40-70.1%	$1.34

NBLWF Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$7.5B-5.5%	$8.0B+44.6%	$5.5B+5.2%	$5.2B+152.5%	$2.1B+21.5%	$1.7B
Current Assets	$1.3B-8.4%	$1.4B+30.8%	$1.1B+0.9%	$1.1B+130.8%	$455.6M+24.4%	$366.4M
Cash & Equivalents	$471.4M+90.6%	$247.3M-31.5%	$360.8M-24.2%	$476.2M+145.3%	$194.1M+73.4%	$112.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$589.6M-26.0%	$797.0M+45.2%	$548.8M+17.1%	$468.8M+133.9%	$200.4M+5.9%	$189.2M
Goodwill	N/A	N/A	$0-100.0%	$26.0M	$0	N/A
Total Liabilities	$3.0B-10.0%	$3.3B+108.9%	$1.6B-2.6%	$1.6B+184.2%	$572.8M-71.6%	$2.0B
Current Liabilities	$759.7M-19.2%	$940.4M+46.5%	$641.7M-3.8%	$667.1M+168.6%	$248.4M+34.0%	$185.4M
Long-Term Debt	$2.0B-0.2%	$2.0B+237.8%	$586.2M+14.3%	$513.1M+137.5%	$216.0M-45.1%	$393.5M
Total Equity	$4.5B-2.2%	$4.7B+18.6%	$3.9B+8.7%	$3.6B+140.4%	$1.5B+581.9%	-$311.4M
Retained Earnings	$286.6M-30.3%	$411.2M-24.0%	$541.2M+111.4%	$255.9M+151.0%	$102.0M	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$7.5B-0.7%	$7.5B-1.4%	$7.6B-0.4%	$7.7B-3.1%	$7.9B-0.7%	$8.0B-0.9%	$8.0B+43.8%	$5.6B
Current Assets	$1.4B+12.8%	$1.3B-6.8%	$1.4B+5.8%	$1.3B-10.7%	$1.4B+3.9%	$1.4B-1.5%	$1.4B+42.9%	$986.9M
Cash & Equivalents	$662.6M+40.6%	$471.4M-1.4%	$477.9M+41.3%	$338.2M+11.3%	$303.8M+22.8%	$247.3M-36.9%	$391.9M+140.6%	$162.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$595.9M+1.1%	$589.6M-13.1%	$678.3M-11.0%	$761.7M+0.7%	$756.3M-5.1%	$797.0M+5.9%	$752.3M+18.1%	$637.0M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.9B-3.0%	$3.0B-4.0%	$3.1B+2.2%	$3.0B-6.6%	$3.3B-1.9%	$3.3B-1.1%	$3.4B+109.1%	$1.6B
Current Liabilities	$719.4M-5.3%	$759.7M-2.5%	$779.3M+8.8%	$716.0M-22.2%	$920.0M-2.2%	$940.4M+4.4%	$900.5M+41.4%	$637.0M
Long-Term Debt	$1.9B-3.0%	$2.0B-0.1%	$2.0B-0.1%	$2.0B0.0%	$2.0B-0.1%	$2.0B-0.1%	$2.0B+218.5%	$622.1M
Total Equity	$4.6B+0.9%	$4.5B+0.3%	$4.5B-2.0%	$4.6B-0.6%	$4.7B+0.1%	$4.7B-0.7%	$4.7B+17.6%	$4.0B
Retained Earnings	$324.8M+13.3%	$286.6M+2.3%	$280.1M-26.6%	$381.5M-9.1%	$419.6M+2.0%	$411.2M-7.6%	$445.1M-30.9%	$643.9M

NBLWF Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$951.7M+45.2%	$655.5M+14.1%	$574.3M+104.4%	$281.0M+444.4%	$51.6M-81.1%	$273.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$350.1M+63.5%	-$959.0M-161.7%	-$366.5M-197.5%	$375.8M+80.8%	$207.9M+271.1%	-$121.5M
Financing Cash Flow	-$373.9M-298.8%	$188.1M+157.7%	-$325.8M+11.4%	-$367.8M-108.1%	-$176.8M-264.5%	$107.4M
Dividends Paid	$320.4M+15.3%	$277.8M+181.2%	$98.8M	$0	$0	N/A
Share Buybacks	$20.0M-93.3%	$300.0M+216.4%	$94.8M+532.2%	$15.0M	$0	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$273.3M+46.0%	$187.1M-32.5%	$277.1M+28.1%	$216.4M-20.2%	$271.1M+99.0%	$136.2M-52.0%	$283.8M+165.7%	$106.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$102.5M+196.4%	-$106.4M-104.8%	-$52.0M+44.5%	-$93.6M+4.7%	-$98.1M+32.4%	-$145.2M+71.7%	-$514.0M-285.9%	-$133.2M
Financing Cash Flow	-$189.2M-121.8%	-$85.3M+1.0%	-$86.1M-0.1%	-$86.1M+26.1%	-$116.5M+19.0%	-$143.8M-130.8%	$466.8M+2213.9%	-$22.1M
Dividends Paid	$83.7M+4.7%	$79.9M+0.5%	$79.5M0.0%	$79.5M-2.3%	$81.4M+2.2%	$79.7M-2.3%	$81.6M-37.2%	$129.9M
Share Buybacks	$0	$0	$0	$0-100.0%	$20.0M-60.0%	$50.0M-80.0%	$250.0M	$0

NBLWF Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	12.7%-7.1pp	19.8%-2.4pp	22.2%+6.0pp	16.2%+8.3pp	7.9%+430.7pp	-422.8%
Net Margin	6.6%-8.1pp	14.7%-3.9pp	18.6%+6.7pp	11.9%-1.3pp	13.2%+425.8pp	-412.6%
Return on Equity	4.8%-4.9pp	9.6%-2.6pp	12.3%+7.6pp	4.7%-2.1pp	6.8%	N/A
Return on Assets	2.9%-2.8pp	5.6%-3.1pp	8.8%+5.5pp	3.2%-1.7pp	4.9%+238.1pp	-233.2%
Current Ratio	1.67+0.2	1.48-0.2	1.65+0.1	1.58-0.3	1.83-0.1	1.98
Debt-to-Equity	0.430.0	0.43+0.3	0.150.0	0.140.0	0.14+1.4	-1.26
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	28.7%+23.1pp	5.6%-0.8pp	6.3%-9.6pp	15.9%-5.5pp	21.4%+3.0pp	18.4%+4.0pp	14.4%-15.9pp	30.3%
Net Margin	15.4%+4.0pp	11.3%+14.0pp	-2.6%-7.7pp	5.1%-7.3pp	12.4%+2.0pp	10.4%+2.8pp	7.6%-20.5pp	28.1%
Return on Equity	2.6%+0.7pp	1.9%+2.4pp	-0.5%-1.4pp	0.9%-1.4pp	2.3%+0.3pp	2.1%+0.8pp	1.3%-3.6pp	4.9%
Return on Assets	1.6%+0.5pp	1.1%+1.4pp	-0.3%-0.8pp	0.6%-0.8pp	1.4%+0.2pp	1.2%+0.4pp	0.8%-2.7pp	3.5%
Current Ratio	1.99+0.3	1.67-0.1	1.75-0.0	1.80+0.2	1.57+0.1	1.48-0.1	1.57+0.0	1.55
Debt-to-Equity	0.42-0.0	0.430.0	0.440.0	0.430.0	0.420.0	0.430.0	0.42+0.3	0.16
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Nobel's annual revenue?

Nobel (NBLWF) reported $3.3B in total revenue for fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nobel's revenue growing?

Nobel (NBLWF) revenue grew by 7.4% year-over-year, from $3.1B to $3.3B in fiscal year 2025.

Is Nobel profitable?

Yes, Nobel (NBLWF) reported a net income of $216.7M in fiscal year 2025, with a net profit margin of 6.6%.

How much debt does Nobel have?

As of fiscal year 2025, Nobel (NBLWF) had $471.4M in cash and equivalents against $2.0B in long-term debt.

What is Nobel's operating margin?

Nobel (NBLWF) had an operating margin of 12.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Nobel's net profit margin?

Nobel (NBLWF) had a net profit margin of 6.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Nobel pay dividends?

Yes, Nobel (NBLWF) paid $2.00 per share in dividends during fiscal year 2025.

What is Nobel's return on equity (ROE)?

Nobel (NBLWF) has a return on equity of 4.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Nobel's operating cash flow?

Nobel (NBLWF) generated $951.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Nobel's total assets?

Nobel (NBLWF) had $7.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Nobel buy back shares?

Yes, Nobel (NBLWF) spent $20.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Nobel have outstanding?

Nobel (NBLWF) had 159M shares outstanding as of fiscal year 2025.

What is Nobel's current ratio?

Nobel (NBLWF) had a current ratio of 1.67 as of fiscal year 2025, which is generally considered healthy.

What is Nobel's debt-to-equity ratio?

Nobel (NBLWF) had a debt-to-equity ratio of 0.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nobel's return on assets (ROA)?

Nobel (NBLWF) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Nobel's Piotroski F-Score?

Nobel (NBLWF) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nobel's earnings high quality?

Nobel (NBLWF) has an earnings quality ratio of 4.39x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Nobel cover its interest payments?

Nobel (NBLWF) has an interest coverage ratio of 2.6x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.